07 Jan 2019

MDLINX SURVEY: MAJORITY HAVE LOST FAITH IN VALUE OF THE MOC

A survey of 515 U.S. physicians by MDLinx revealed that 65 percent want to see the 10-year maintenance of certification (MOC) process ended because it adds no clinical value to the practice of medicine. The recent survey, reported in FierceHealthcare, found that almost 55 percent of respondents want to see those controversial MOC requirements

0
07 Jan 2019

MEDTRONIC GETS OK TO STUDY PATIENTS WITH BICUSPID AORTIC VALUES USING COREVALVE EVOLUT TAVR SYSTEM

The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for Medtronic to initiate a single-arm study to evaluate the CoreValve Evolut TAVR system in patients with bicuspid aortic valves who are at low risk of surgical mortality. Medtronic separately received FDA approval for revised commercial

0
07 Jan 2019

GERMAN UNIVERSITY ADDS NEW STUDY IN MEDICAL COMPUTING

  The Fraunhofer MEVIS Institute for Medical Image Computing is one of the world’s leading research centers in digital medicine. In order to prepare computer science students for challenges in this area, the Fraunhofer MEVIS Institute for Medical Image Computing and the University of Bremen in Germany are offering a

0
05 Jan 2019

WHEN MEDICINE MAKES PATIENTS SICKER

  By Sydney Lupkin Photos by Heidi de Marco Despite the jackhammer-like rhythm of a mechanical ventilator, Alicia Moreno had dozed off in a chair by her 1-year-old’s hospital bed, when a doctor woke her with some bad news: The common stool softener her son, Anderson, was given months earlier had been

0
05 Jan 2019

AS HOSPITALS POST STICKER PRICES ONLINE, MOST PATIENTS WILL REMAIN BEFUDDLED

    By Julie Appleby and Barbara Feder Ostrov As of Jan. 1, in the name of transparency, the Trump administration required that all hospitals post their list prices online. But what is popping up on medical center websites is a dog’s breakfast of medical codes, abbreviations and dollar signs — in little

0
05 Jan 2019

IT’S A LITTLE-KNOWN SECRET THAT PATIENTS CAN GET THOUSANDS OF DOLLARS DIRECTLY FROM A DRUGMAKER

      By Sarah Jane Tribble   Kip Burgess was relieved last year when pharmaceutical giant Amgen overnighted him a $2,976 check to help pay for his go-to arthritis drug, Enbrel. The 36-year-old psychologist had run into an increasingly common problem: The copay coupon sent by Thousand Oaks, Calif.-based Amgen

0
03 Jan 2019

IN.PACT ADMIRAL:  MEDTRONIC SHARES FIVE-YEAR DRUG-COATED BALLOON DATA

  Medtronic plc data presented Nov. 12 reinforce the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral artery disease in the superficial femoral and popliteal arteries. The five-year and final results from the pivotal IN.PACT SFA Trial and one-year all-subjects results from the

0
03 Jan 2019

KENNETH OSORIO, MD: A successful vein specialist leads missions of mercy to Caraz, Peru

  By John A. Chuback, MD, FACS, RPVI, RVT, RPhS   Kenneth Osorio, MD, is a successful phlebologist and the medical director of Advanced Vein Center, a very active clinical practice in Mesa, Arizona. Despite his many professional accomplishments, he has not forgotten his roots; nor has Dr. Osorio forgotten

0
03 Jan 2019

OFFICE MANAGERS CAN MAKE OR BREAK YOUR PRACTICE

  By Jeffrey Miller How important are your office managers? Important in any business, they are particularly valuable in healthcare. In fact, they can single handedly make the difference between your practice’s success and failure. An excerpt from the book “All In” drives this message home:   Recently, we worked

0
03 Jan 2019

TREATING TORTUOUS VEINS: ‘I have chosen not to treat my patients…by administering PCF’

  By Eric Wellons, MD As a physician who treats patients with varicose veins, I have a variety of tools at my disposal that can relieve the significant disability brought on by the symptoms of this common vascular condition, such as achiness and a “heavy” feeling in the legs. In

0